The recognition that human papillomavirus (HPV) infection is the central, necessary cause of
cervical cancer paved the way to new fronts of prevention via improved screening methods …

Human papillomavirus (HPV) is the necessary cause of cervical cancer, the fourth most
common cancer and cause of cancer-related death in females worldwide. HPV also causes …

More than 120 different types of the human papillomavirus (HPV) have been isolated;> 40 of
these types infect the epithelial lining of the anogenital tract and other mucosal areas. In the …

A small number of HPV types are related to a majority of HPV-related neoplastic lesions in
humans. High-risk types such as HPV 16 and 18 are most often implicated, although other …

Genital HPV infection is associated with development of cervical cancer, cervical neoplasia,
anogenital warts, and other anogenital cancers. A number of reviews have primarily …

Abstract Cervarix® and Gardasil®, 2 human papillomavirus (HPV) vaccines, have been
approved and implemented globally in young adolescent women with the hope of reducing …

Quadrivalent human papillomavirus (HPV)[types 6, 11, 16, 18] recombinant vaccine
(Gardasil®; Silgard®) is composed of virus-like particles formed by self-assembly of …

The majority of human papillomavirus (HPV) belong to the genus alpha-papillomavirus,
which can be further subdivided into species and then strains. Approximately 200 strains of …

Background. Cellular immunity is involved in spontaneous clearance of anogenital warts
caused, most typically, by human papillomavirus (HPV) type 6 or 11, supporting the concept …

Persistent infection with oncogenic human papillomavirus (HPV) is a necessary causal
factor in the development of cervical cancer. Moreover, HPV, predominately type 16 and to a …